Are you a Big Pharma Compnay looking to make up sales shortfalls in emerging countries? Well, scratch India off your list of profit centers.
India's drug controller, GN Singh, wants to prohibit the sale of branded pharmaceuticals in India in favor of lower cost generics. States have been ordered to stop issuing licenses for manufacturing licenses for drugs under brand names. Manufacturers have been asked to submit their products for licensing under generic names -- not brand names.
"We have sent the order to all state health secretaries asking them to instruct their drug licensing issuing authority to issue licenses only on generic names and not on branded or trade names, which is the usual practice now. A branded drug can be 10 times more expensive than a generic variant," said Singh. In addition, the government will open its own chain of medical stores to make generics available at a reasonable cost.
They seem to be as serious as a heart attack in cutting drug costs in India.
Posted by Bruce Lehr Oct 17th 2012.